ER-to-Golgi transport in yeast may be reproduced in vitro with washed membranes, purified proteins (COPII, Uso1p and LMA1) and energy. COPII coated vesicles that have budded from the ER are freely diffusible but then dock to Golgi membranes upon the addition of Uso1p. LMA1 and Sec18p are required for vesicle fusion after Uso1p function. Here, we report that the docking reaction is sensitive to excess levels of Sec19p (GDI), a treatment that removes the GTPase, Ypt1p. Once docked, however, vesicle fusion is no longer sensitive to GDI. In vitro binding experiments demonstrate that the amount of Uso1p associated with membranes is reduced when incubated with GDI and correlates with the level of membrane-bound Ypt1p, suggesting that this GTPase regulates Uso1p binding to membranes. To determine the influence of SNARE proteins on the vesicle docking step, thermosensitive mutations in Sed5p, Bet1p, Bos1p and Sly1p that prevent ER-to-Golgi transport in vitro at restrictive temperatures were employed. These mutations do not interfere with Uso1p-mediated docking, but block membrane fusion. We propose that an initial vesicle docking event of ER-derived vesicles, termed tethering, depends on Uso1p and Ypt1p but is independent of SNARE proteins.
Introduction
Transport vesicle intermediates shuttle cargo between intracellular organelles through cycles of budding and membrane fusion. Vesicle budding from intracellular compartments is catalyzed by distinct sets of coat proteins that are shed prior to vesicle fusion (Schekman and Orci, 1996) . For intracellular vesicle fusion, a conceptual framework is emerging whereby a set of general fusion factors, such as NSF/Sec18p and SNAP/Sec17p, act in concert with a related cast of compartment-specific factors, such as Rab/Ypt proteins and SNARE proteins (Rothman, 1994) . The underlying mechanisms of intracellular membrane fusion appear to be conserved both within a species and from yeast to mammals, although a molecular description of this process is incomplete (for review, see Pfeffer, 1996) . We are investigating this basic cell biological 2156 © Oxford University Press process through elucidation of vesicle fusion to the Golgi complex in the yeast Saccharomyces cerevisiae.
Several lines of experimental evidence indicate that vesicular transport from the ER to the Golgi in yeast is mediated by an ordered series of reactions: vesicle budding; vesicle docking; and membrane fusion (Kaiser and Schekman, 1990; Rexach and Schekman, 1991) . The first reaction in this process, vesicle budding, may be reproduced in vitro with ER membranes and a set of soluble factors (Sar1p, Sec13p complex and Sec23p complex) that generate transport intermediates, termed COPII coated vesicles (Salama et al., 1993; Barlowe et al., 1994) . The vesicle intermediates produced in vitro are distinct from the donor membranes in that they are enriched for cargo protein over resident ER protein. Furthermore, these intermediates are competent for fusion with the Golgi complex in a reaction requiring cytosol, ATP and GTP (Barlowe et al., 1994; Rexach et al., 1994; Lupashin et al., 1996) . This assay was employed to isolate a minimal set of soluble proteins (Uso1p, Sec18p and LMA1) that replace the cytosol requirement for vesicle fusion. For overall ER-to-Golgi transport in yeast semi-intact cells, COPII proteins are required in addition to the isolated fusion factors, indicating that vesicle fusion is coupled to vesicle budding. Uso1p mediates vesicle docking and produces a dilution-resistant intermediate. Sec18p and LMA1 are not required for the docking phase, but are required for efficient fusion of vesicles (Barlowe, 1997) .
These isolated fusion factors represent some, but not all, of the genetic requirements for fusion of ER-derived vesicles, established by analyses of secretion-defective cells (Kaiser et al., 1997) . In this report, we use a reconstituted ER-to-Golgi transport assay to examine the roles of Sed5p, Sly1p, Bet1p, Bos1p and Ypt1p through selective inactivation of their functions. The integral membrane protein, Sed5p, is related to a family of target-SNARE (t-SNARE) proteins, and functions in transport from the ER to the Golgi complex in vivo (Hardwick and Pelham, 1992) . Sly1p is a member of the Sec1 family of proteins, is peripherally associated with membranes and is required for ER-to-Golgi transport in vivo and in vitro (Dascher et al., 1991; Mizuta et al., 1994; Lupashin et al., 1996) . Bet1p and Bos1p are essential ER-to-Golgi vesicleSNAREs (v-SNAREs; Newman et al., 1990; Shim et al., 1991; Lian and Ferro-Novick, 1993) , and in vitro experiments with purified proteins demonstrate that Bet1p increases the affinity of Bos1p binding to Sed5p (Stone et al., 1997) . Ypt1p is essential for two steps in the yeast secretory pathway, ER-to-Golgi transport and transport between Golgi compartments (Segev et al., 1988) . Ypt1p belongs to the Rab/Ypt family of GTPases which, in general, are thought to ensure the fidelity of vesicle targeting (Bourne et al., 1991; Rexach and Schekman, 1991; Segev, 1991) . Immunoprecipitation experiments from detergent lysates demonstrate Sed5p, Bet1p, Bos1p and Sly1p are in a stable SNARE complex when Sec18p is inactive (Sogaard et al., 1994) . Ypt1p is proposed to regulate the assembly of this SNARE complex and a fraction of Ypt1p is also detected in association with Sed5p (Lian et al., 1994; Sogaard et al., 1994; Lupashin and Waters, 1997) . After inactivation of Ypt1p, we find that Uso1p binding to membranes is prevented and ERderived vesicles fail to dock. However, inactivation of Sed5p, Sly1p, Bet1p and Bos1p do not interfere with vesicle docking but prevent subsequent fusion. These results indicate that Uso1p mediated docking of ERderived vesicles requires Ypt1p but does not rely directly on SNARE protein function.
Results

GDI inhibits ER-to-Golgi transport, but does not affect vesicle budding
Ypt1p, a small GTPase belonging to the Ypt/Rab family, is required for ER-to-Golgi transport in vivo (Segev et al., 1988) and in vitro (Baker et al., 1990) . Yeast semi-intact cells prepared from a ypt1-ts strain or wild-type reactions inhibited by the addition of anti-Ypt1p Fabs accumulate ER-derived vesicles (Rexach and Schekman, 1991; Segev, 1991; Rexach et al., 1994) , suggesting that Ypt1p is involved in docking ER-derived vesicles to the Golgi. We wanted to examine the role of Ypt1 in the Uso1p-dependent docking reaction using an ER-to-Golgi transport assay that depends on washed membranes and purified proteins (Barlowe, 1997) . We first chose to inhibit Ypt1p activity by addition of GDI (Sec19p), since this inhibitor may be added at various stages of the transport reaction and allows us to establish a kinetic relationship of Ypt1p function with vesicle docking and membrane fusion. Excess levels of GDI extract GDP-bound forms of Rab/Ypt proteins from membranes and form soluble heterodimers in vitro Sasaki et al., 1990) . Elevated levels of GDI have been shown to extract a broad range of Rab/ Ypt proteins and inhibit several intracellular transport reactions (Ullrich et al., 1993; Dirac-Svejstrup, 1994; Peter et al., 1994 , Haas et al., 1995 . Physiological levels of GDI in cells are thought to participate in the general regulation of the Rab/Ypt GTPase cycle and are essential for cell viability (Novick et al., 1980; Garrett et al., 1994) . First, we titrated the level of GDI required to inhibit our reconstituted ER-to-Golgi transport assay. In these experiments, washed semi-intact cells containing [ 35 S]gp-α-factor were incubated with COPII proteins, Uso1p, LMA1 and an ATP/GTP regeneration system. Additional Sec18p is not required in this assay because semi-intact cells contain ample membrane-bound Sec18p (Barlowe, 1997) . Under these conditions, GDI concentrations Ͼ40 μg/ml inhibit transport ( Figure 1A ). Increasing the amount of purified GDI resulted in a dose-dependent inhibition of transport. To demonstrate that GDI inhibition of the reconstituted ER-to-Golgi transport assay was specific to later stages and not formation of ER-derived vesicles, we measured the rate of vesicle formation ( Figure 1B) in the presence or absence of 200 μg/ml GDI. In this experiment, washed semi-intact cells containing [ 35 S]gp-α-factor were incubated with COPII proteins and an ATP/GTP regeneration system. Over time, ER-derived vesicles containing [ 35 S]gp-α-factor were released as diffusible intermediates that remained in the supernatant fraction after centrifugation at 18 000 g. A concentration of GDI that inhibits transport does not reduce the rate or extent of budding driven by COPII. Experiments using crude cytosol to drive vesicle budding and transport produced a similar result (data not shown). Therefore, we conclude that GDI inhibits transport, but not vesicle budding.
GDI inhibits vesicle docking, not fusion
Next, we studied the influence of GDI on the processes of vesicle docking and fusion. ER-derived vesicles dock to Golgi membranes and produce a dilution-resistant intermediate in the presence of Uso1p (Barlowe, 1997) . To determine the effect of GDI on vesicle docking (Figure 2A ), semi-intact cells were incubated with COPII while varying the order of Uso1p and GDI additions. Incubations with COPII and Uso1p, followed by addition of buffer at indicated time points, shows that the vesicles produced were efficiently docked under this condition ( Figure 2A , open squares) whereas the COPII plus GDI condition produces vesicles that remained freely diffusible ( Figure 2A , open circles). Reactions containing COPII plus GDI, followed by addition of Uso1p at indicated times, did not reduce the level of diffusible vesicles ( Figure 2A , closed circles), and shows that GDI prevents docking. Finally, mixtures containing COPII plus Uso1p, followed by a time course of GDI addition, revealed a temporal sensitivity to GDI. Thus, GDI inhibits the docking reaction catalyzed by Uso1p but, once docked, GDI can not reverse this reaction.
Because GDI prevents vesicle docking, the effects of this inhibitor on transport should exhibit similar kinetics ( Figure 2B ). In this experiment, LMA1 was included to drive vesicle fusion, and GDI was added at indicated time points. Again, addition of GDI at early time points inhibited fusion due to a failure of vesicles to dock. At 10 min, vesicle docking had neared completion (Figure 2A , squares), and indeed, transport was largely insensitive to GDI after this time. This result suggests that membrane fusion is not sensitive to GDI. However, the conditions of this experiment would not prevent fusion should it occur instantly after docking, since LMA1 is present at the start of reactions. To address this possibility, we formed docked intermediates with COPII and Uso1p for 30 min, then added GDI and LMA1 simultaneously, to test the effect of GDI on LMA1-catalyzed fusion. As seen in Figure 3 , addition of LMA1 at the start of the reaction or after 30 min with GDI produced efficient fusion (compare hatched bars, columns 3 and 4). In summary, once ER-derived vesicles have docked, GDI cannot reverse the docked species, nor can it interfere with the membrane fusion reaction even if added concomitantly with LMA1.
GDI extracts Ypt1p and prevents Uso1p binding
Based on the above observations, we speculate that Ypt1p regulates Uso1p membrane association in docking ERderived vesicles to the Golgi complex. If Ypt1p comprises a binding site for Uso1p, then removal of this GTPase should reduce the amount of Uso1p associated with membranes. Uso1p behaves as a peripheral membrane protein in cell fractionation studies (Seog et al., 1994) . Most of the Uso1p partitions to a 100 000 g supernatant fluid, but a significant fraction of this species sediments with the 100 000 g pellet. To determine the influence of GDI on Uso1p membrane association, we employed a medium speed supernatant fraction containing cytosol and Golgi membranes that is active for vesicle docking and fusion. Incubation of this extract with GDI reveals a dose-dependent extraction of Ypt1p and a corresponding decrease in Uso1p from the 100 000 g pellet fraction ( Figure 4A ). The GDI treatment does not affect the integrity of Golgi membranes as evidenced by equal recovery of the Golgi localized integral membrane protein Emp47p (Schroder et al., 1995) . Furthermore, GDI does not act as a general chaotropic agent because the level of peripherally associated Sly1p is not affected by this treatment.
GDI extraction is specific for the GDP forms of Rab/Ypt proteins and is not effective if the GTPase is bound to a non-hydrolyzable analog of GTP, such as GTPγS Garrett et al., 1993) . Preincubation of extracts with GTPγS (0.4 mM) reduced the level of extractable Ypt1p and mirrored the level of extractable Uso1p. In similar experiments, we have examined Uso1p binding to mutant ypt1-3 membranes, and found that reduced levels of both Ypt1p and Uso1p bound after incubation at permissive and restrictive temperatures (data not shown). Therefore, we conclude that the membrane association of Uso1p correlates strictly with the level of membrane-bound Ypt1p. Uso1p could bind directly to Ypt1p or, alternatively, Ypt1p could regulate an Uso1p receptor complex. Membranes were isolated by centrifugation at 100 000 g and the resulting pellets washed with Buffer 88 and spun again. The final pellet was resuspended with SDS-PAGE sample buffer and resolved on 12.5 or 7% polyacrylamide gels. Immunoblot analyses using the ECL detection method document the content of individual proteins contained in the membrane pellet. (B) The experiment is similar to (A), except lysates were pre-incubated with GTPγS (0.4 mM) prior to the addition of GDI.
SNARE molecules are not required for Uso1p docking
Uso1p and Ypt1p represent some, but not all, of the requirements for fusion of ER-derived vesicles. Genetic and biochemical approaches have implicated Sec22p, Bet1p, Bos1p, Sly1p, Sed5p and Ykt6, in this step of ERto-Golgi transport (Newman et al., 1990 (Newman et al., , 1992 Dascher et al., 1991; Hardwick et al., 1992; Sogaard et al., 1994) . Several of these proteins are found in a stable SNARE complex when isolated from a sec18-1 strain (Sogaard et al., 1994) . Interestingly, Uso1p and Ypt1p are not found in a stable association with the isolated SNARE complex (Sapperstein et al., 1995; Lupashin et al., 1997) . We speculate that the SNARE proteins are not required for docking of ER-derived vesicles since Sec18p was not required for formation of an Uso1p dilution-resistant intermediate (Barlowe, 1997) . However, there are alternative explanations for this result depending on the model for Sec18p function that is favored. The SNARE hypothesis proposes that pairing of v-SNARE with t-SNARE docks vesicles in a Sec18p/NSF-independent process, followed by recruitment of Sec18p/NSF to form the 20S complex. ATP hydrolysis by Sec18p/NSF dissociates SNARE proteins and permits membrane fusion (Sollner et al., 1993; Sogaard, 1994) . Therefore, Sec18p-independent docking is consistent with the SNARE hypothesis as proposed by Rothman and colleagues (Sollner et al., 1993) . However, recent studies suggest Sec18p is indeed required for ATPcatalyzed separation of SNARE proteins, but that this . sly1-ts mutation alters an invariant arginine residue. Amino acid sequence of Sly1p surrounding the temperature-sensitive mutation and comparison with selected homologues. Sly1p contains five domains that share high sequence identity (25-47%) with a family of related proteins. In the sly1-ts strain, arginine 266 (highlighted) is converted to a lysine. The amino acid numbers in parentheses correspond to the first residue shown, and the abbreviations are as follows: Sly1, Sly1p from S.cerevisiae (Z48784); rSly1, rat Sly1p (U57687); Unc18, Caenorhabditis elegans unc-18 (S66176); cUnc18, Caenorhabditis briggsae unc-18 homologue (D63505); n-Sec1, neuronal Sec1p homologue from rat (A53455); scSec1, S.cerevisiae Sec1p (P30619); Vps45, S.cerevisiae Vps45p (U07972); mVps45, mouse Vps45p homologue (U66865); Rop, Ras2 opposite protein from Drosophila melanogaster (S33578).
reaction activates SNARE proteins and precedes docking (Mayer et al., 1996; Ungermann et al., 1998) . Regardless of the precise temporal mode of Sec18p action, both models postulate that SNARE proteins dock donor and acceptor membranes. We pursued a series of experiments to determine if Sed5p (t-SNARE) and the Sed5p associated protein, Sly1p, participate in formation of Uso1p docked vesicles.
The sed5-1 allele was isolated through an in vitro mutagenesis approach and is due to a single point mutation (R255G) that results in temperature-sensitive (ts) growth. At 25°C, sed5-1 strains grow and transport secretory proteins whereas growth is inhibited at 37°C and ERforms of secretory proteins accumulate (Banfield et al., 1995) . The sly1-ts allele was identified in a screen for ribosome-synthesis mutants, and it was subsequently determined that several mutations blocking the secretory process, in general, inhibit expression of ribosomal subunits (Mizuta and Warner, 1994) . Again, sly1-ts strains grow at 25°C but when shifted to 37°C, growth is inhibited and ER-forms of secretory proteins accumulate (Mizuta and Warner, 1994) . We recovered the sly1-ts allele for sequence analysis and determined that temperature sensitivity is due to a single point mutation (R266K) in Sly1p that alters an invariant amino acid residue found in the Sec1p family of proteins ( Figure 5 ). It remains to be determined whether mutation of this residue in other family members produces temperature-sensitive phenotypes. Examination of the sly1-ts strain indicates that the expression level and subcellular fractionation behavior of the Sly1p-R266K protein is indistinguishable from the wild-type species (data not shown). Both the sed5-1 and sly1-ts alleles are recessive mutations.
We prepared an isogenic set of strains (wild-type, ypt1-3, sed5-1 and sly1-ts) for comparison of vesicle docking and fusion in our reconstituted assay. All strains were grown at 23°C before preparation of semi-intact cells. Addition of purified COPII and fusion factors drove ER-to-Golgi transport in these strains when the reaction temperature was 23°C (Figure 6 ). However, membranes prepared from the sed5-1 and sly1-ts strains display temperature sensitivity in transport, with a marked inhibition observed at 29°C (Figure 6 ). For the ypt1-3 strain, transport was reduced even at permissive temperatures, but completely blocked at 29°C (data not shown). This reduced level of transport at 23°C is probably due to lower amounts of mutant Ypt1p in these cells (Sogaard et al., 1994) . These results indicate that loss-of-function mutations in Ypt1p, Sly1p and Sed5p prevent delivery of [ 35 S]gp-α-factor to the Golgi complex. To distinguish between possible defects in vesicle docking and fusion, we measured the level of freely diffusible ER-derived vesicles in the presence and absence of Uso1p (Figure 7) . Docking in the ypt1-3 strain was inhibited at 29°C and reduced compared with a wildtype strain at 23°C (Figure 7A and B) . Vesicle docking achieved through Uso1p function was efficient in sly1-ts and sed5-1 strains at permissive and restrictive temperatures ( Figure 7C and D) . Furthermore, docking remains equally sensitive to GDI treatment in the mutant strains at 29°C as was observed in wild-type reactions at 23°C (data not shown). In summary, these results suggest docking of ER-derived vesicles does not directly require Sed5p and Sly1p, but subsequent fusion depends on their activity.
As an independent approach to determine the role of Sed5p in vesicle docking and fusion, we used neutralizing antibodies specific for Sed5p to inhibit function. Antibodies were raised against a synthetic peptide comprising the N-terminal 28 amino acid residues of Sed5p and tested for inhibition of in vitro transport. A titration of antiSed5p (from total immune IgG) showed potent inhibition of reconstituted transport that was maximal at 0.25 mg/ml (data not shown). Furthermore, this inhibition could be alleviated by incubation of immune IgG with the synthetic peptide used to illicit the anti-Sed5p immune response ( Figure 8A ). Antibody inhibition could be reversed if competitor peptide was added at t 0 or after a 20 min incubation under standard assay conditions (data not shown). The reversibility of the anti-Sed5p block demonstrates that this inhibition is specific and does not damage Sed5p or proteins associated with this t-SNARE. When the docking assay was performed in the presence of inhibitory concentrations of anti-Sed5p IgG ( Figure 8B) , Uso1p reduced the level of freely diffusible vesicles as efficiently as in untreated reactions. The addition of antiSed5p IgG does not affect the vesicle budding reaction ( Figure 8B , third column), excluding the possibility that the reduction in freely diffusible vesicles was due to inhibition of the budding step. In summary, antibody inhibition of Sed5p function confirms results obtained using the sed5-1 allele that this t-SNARE is required for membrane fusion but not for vesicle docking.
Our results demonstrate a clear role for Sed5p and Sly1p in overall transport, yet these proteins are not required for the initial vesicle docking stage. However, recent evidence indicates that there is not a strict separation of t-SNAREs to target compartments and v-SNAREs to donor vesicle compartments (Walch-Solimena et al., 1995;  C.Barlowe and X.Cao, unpublished observation), and we explored the possibility that v-SNARE molecules such as Bet1p and Bos1p provide necessary SNARE contacts during Uso1p-mediated docking. We used temperaturesensitive bet1-1 and bos1-1 mutations in our reconstituted docking and transport assays. As with the sed5-1 and sly1-ts alleles, these are recessive loss-of-function mutations in vivo (Wuestehube et al., 1996) . As seen in Figure 9 , temperature profiles of these mutant strains in reconstituted transport show efficient transport at 23°C, whereas a marked inhibition was observed in both mutant strains at 29°C compared with their wild-type counterpart strain RSY255). Finally, docking in the bet1-1 and bos1-1 semi-intact cells was comparable with wild-type when Uso1p was added to the reactions (Figure 10) . Therefore, we conclude that in addition to the t-SNARE protein Sed5p, the v-SNARES Bet1p and Bos1p are not required for initial docking of ER-derived vesicles to the Golgi complex. In contrast, two independent approaches (GDI extraction or mutation of Ypt1p) demonstrate that Ypt1p function is required for this docking reaction.
Discussion
In this report, we demonstrate that initial docking of ERderived vesicles depends on Uso1p and Ypt1p, but does not require the SNARE proteins Sed5p, Bet1p or Bos1p. We will refer to this Uso1p-dependent step as 'tethering' to distinguish it from docking reactions mediated by SNARE proteins (Sollner et al., 1993) . This Uso1p-tethered vesicle is a functional intermediate that is no longer sensitive to GDI, but requires the action of Sed5p, Bet1p, Bos1p, Sly1p, Sec18p and LMA1 for fusion. A model, based on these results and a series of genetic experiments, is proposed as follows. First, uncoated ERderived vesicles bind Uso1p and are tethered to Golgi membranes in a Ypt1p-dependent process. Next, the tethering event transmits a signal to the SNARE machinery, possibly through activation of Ypt1p. Once this signal is received, SNARE proteins are paired and vesicles fuse through the action of Sec18p and LMA1. This model is consistent with a general hypothesis for intracellular transport where distinct vesicles find their target site more efficiently via GTPase regulated 'Velcro' factors (Pfeffer, 1996) . In the case of ER-to-Golgi transport, Uso1p probably represents the Velcro molecule that leads to pairing of v-and t-SNARE proteins. Aspects of this model are now considered in the context of reported genetic and in vitro observations. The participation of Uso1p and Ypt1p in a distinct biochemical reaction prior to Sed5p, Sly1p, Bet1p and Bos1p function is compatible with genetic analyses in yeast. Overexpression of v-SNARE proteins (Sec22, Bet1p or Bos1p) suppress loss-of-function ypt1 and uso1 mutations. Furthermore, a gain-of-function SLY1 allele (SLY1-20) obviates the need for Uso1p and Ypt1p (Dascher et al., 1991; Sapperstein et al., 1996) . These results have led to the proposal that an increase in active SNARE proteins bypasses the need for Uso1p and Ypt1p function by mass action (Pfeffer, 1996; Sapperstein et al., 1996) . This report now correlates these genetic relationships with the biochemically distinguishable steps of vesicle tethering and SNARE protein-dependent fusion. However, there is genetic and biochemical evidence suggesting that proteins involved in vesicle tethering communicate with downstream SNARE proteins. For example, a complete deletion of USO1 can be weakly suppressed by YPT1 overexpression, but the converse does not hold true (Sapperstein et al., 1996) . Additionally, Ypt1p has been shown to associate transiently with Sed5p (Lupashin and Waters, 1997) . Based on these observations, we speculate that the tethering event transmits information to SNARE proteins, making them competent for activation and thereby ensuring correct SNARE assembly only after vesicle tethering. A primary suspect to relay this signal is the small GTPase, Ypt1p. Our results indicate that, once a vesicle has tethered, fusion is no longer sensitive to GDI, possibly due to conversion of Ypt1p to the GTP-bound form. This event may be transduced to the Sed5p-Sly1p complex. In the absence of Uso1p-mediated tethering in vivo, overproduction of Ypt1p could yield a significant level of GTP-bound Ypt1p and send a false signal that activates downstream SNARE proteins. We suggest activation of Ypt1p to the GTP-bound form is important for activation of SNARE proteins; however, vesicle fusion may not depend on GTP hydrolysis by Ypt1p. This feature is consistent with in vivo results with an activated form of Ypt1p (Richardson et al., 1998) and in vitro analyses with an XTP-dependent form of Rab5 protein (Rybin et al., 1996) , indicating GTP hydrolysis by Ypt/Rab proteins is not directly required for membrane fusion.
Surprisingly, ER-derived vesicles remain tethered in the absence of essential SNARE protein function under our conditions. Previous in vitro analyses indicate Sec18p action is required for vesicle docking when intermediates of ER-to-Golgi transport were analyzed on sucrose gradients (Rexach and Schekman, 1991) . In contrast, we propose Sec18p activity is not required for tethering although the behavior of Uso1p-tethered vesicles on sucrose gradients has not been examined to determine if this intermediate withstands such a treatment. It remains possible that a second stage of docking depends on SNARE proteins and produces a more firmly bound vesicle. We do not think the temperature-sensitive alleles used in these experiments are semi-functional, such that mutant SNARE proteins dock vesicles in a non-productive manner. In vivo, such an effect may produce dominant phenotypes where mutant SNARES would engage vesicles but not fuse, and then block access of subsequent ERderived vesicles. All of the mutations used in these experiments are recessive, loss-of-function mutations. Although we cannot exclude semi-functional activities in vitro, the similar behavior displayed by all of the SNARE alleles tested argues against this possibility. Furthermore, as an independent line of evidence, we have used antibody inhibition specifically to prevent Sed5p function. An identical conclusion is reached, based on these inhibition experiments, that Sed5p is not required for Uso1p tethering.
At present, we can not conclude with certainty whether Uso1p binds directly to Ypt1p, or whether Ypt1p is in association with an Uso1p receptor complex. We are continuing to investigate proteins that bind to Uso1p and the orientation of Uso1p with respect to the docked vesicle and Golgi compartment. Uso1p exists as a parallel homodimer in solution with two globular heads and a long C-terminal coiled-coil domain (Seog et al., 1994; Yamakawa et al., 1996) . Two general models for Uso1p action can be envisaged. First, Uso1p may act asymmetric-ally in vesicle docking such that the tail portion binds to one membrane surface while the globular domain binds to the other. Secondly, Uso1p may tether vesicles through a symmetrical arrangement whereby the head or tail domain binds to both membrane surfaces. Within these two general modes of action, the Uso1p dimer may represent the functional unit, or higher order multimers may form. Since Ypt1p regulates Uso1p binding, a symmetrical model would imply Ypt1p function on both compartments and, at present, there is only evidence to indicate Ypt1p function on the Golgi compartment. Vesicles synthesized from a mutant ypt1 strain are fully functional for fusion with wild-type Golgi membranes . Furthermore, we find that treatment of ER-derived vesicles with GDI prior to isolation on density gradients does not reduce their docking and fusion efficiency (C.Barlowe, unpublished observation). Therefore, we favor some form of the asymmetrical model for the docking process of ER-derived vesicles with the Golgi.
How does Sly1p participate in this process? Sly1p is related to a large family of proteins, including Sec1p, and associates with the t-SNARE molecule Sed5p (Sogaard et al., 1994) . These proteins have been described as a combination of positive and negative regulators (Pevsner et al., 1994; Dascher and Balch, 1996; Lupashin and Waters, 1997 ) that protect the t-SNAREs (Pfeffer, 1996) until an appropriate v-SNARE is presented. The sly1-ts allele employed in our experiments is a recessive, lossof-function mutation and if Sly1p were simply a negative regulator, a loss-of-function mutation could allow tethered vesicles to fuse. However, Sly1p function appears to be required for vesicle fusion in this cell-free reaction after vesicle tethering. Our results are most consistent with a model proposed by Lupahsin and Waters (1997) , and we consider Sly1p to be a component of the t-SNARE, such that a conformational change in the Sly1p-Sed5p complex leads to productive interactions with vesicle SNAREs. The nucleotide-bound state of Ypt1p may influence this conformational change.
We speculate that a tethering event precedes SNARE assembly in vesicular transport processes beyond the ERto-Golgi step. Putative 'Velcro' factors have been identified for endosome-endosome fusion (Stenmark et al., 1995) and for fusion of secretory vesicles with the plasma membrane during exocytosis (Terbush and Novick, 1995) . For synaptic vesicle exocytosis, a tethering activity has also been proposed (Sudhof, 1995) based on the following evidence. Treatment of nerve terminals with botulinum or tetanus toxin cleaves the cognate v-and t-SNAREs (syntaxin and VAMP) and prevents neurotransmitter release. Interestingly, the cleavage event is not accompanied by release of docked vesicles from the pre-synaptic membrane. Instead, vesicles remain firmly attached (Hunt et al., 1994) . This may be explained if there are docking proteins that keep synaptic vesicles tethered to the pre-synaptic membrane in the absence of SNARE protein interactions. Similarly, we find that an essential t-SNARE molecule (Sed5p) is not required for stable docking of ER-derived vesicles to the Golgi complex. Using this refined in vitro system, we continue to explore the molecular detail of this Uso1p-tethered intermediate. 
Materials and methods
General materials and techniques
Yeast strains used in this study are listed in Table I and were grown in rich medium (1% Bacto-yeast extract, 2% Bacto-peptone and 2% dextrose) or selective medium (0.67% nitrogen base without amino acids, 2% dextrose) and required supplements. The sed5-1 and ypt1-3 strains were back-crossed multiple times through the W303 derivative J1003.1D (Mizuta and Warner, 1994) to generate an isogenic set of strains for these studies. Rabbit antiserum specific for α-1,6-mannose linkages was prepared by intravenous injection of heated RSY919 cells as described previously (Ballou, 1970) . For the preparation of Sed5p specific antibodies, a synthetic peptide that contains the N-terminal 28 residues of Sed5p with an added cysteine at position 29 was used as the antigen. This peptide was coupled to BSA (20:1 molar ratio) using the cross-linker disuccinimidyl suberate, and linked conjugates were isolated on a gel filtration column equilibrated in phosphate buffered saline. The peptide-BSA conjugate (~0.5 mg) was mixed with Freund's complete adjuvant and injected into rabbits, followed by monthly boosts with 0.2 mg of conjugate in Freund's incomplete adjuvant. Serum isolated from immunized rabbits cross-reacted with a 46 kDa species on immunoblots, and this reactivity was specifically competed by incubation of synthetic peptide with antiserum prior to immunoblots. IgG was purified from serum using a protein A affinity matrix as described (Harlow and Lane, 1988) . Antibodies directed against Ypt1p , Emp47p (Schroder et al., 1995) and c-Myc (Evan et al., 1985) have been described. Anti-Sly1p serum was a generous gift of H.Dieter Schmitt (Gottingen, Germany). For immunoblots, proteins were resolved by 12.5% SDS-PAGE (Laemmli, 1970) , transferred to nitrocellulose filters (Towbin et al., 1979) and filter-bound primary antibodies were detected by peroxidase-catalyzed chemiluminescence (ECL method, Amersham).
Recovery of the sly1-ts allele
The sly1-ts mutation was isolated by the gap-repair method (Rothstein, 1991) . Plasmid pXC3 contains the complementing 2.5 kb SpeI-EcoRV fragment from pYep51-SLY1 (Dascher et al., 1991) in pRS315 (Sikorski and Heiter, 1989) . Gapped pXC3 (lacking the 1 kb PstI-NsiI fragment) was used to transform strain 312 (sly1-ts) to leucine prototrophy and several temperature-sensitive transformants were obtained. Plasmid DNA was isolated from one of these transformants and amplified in Escherichia coli. The recovered plasmid (pXC3-sly1) contained the full-length gene but could not complement a sly1-ts strain for growth at 37°C. Furthermore, a sly1 null strain harboring pXC3-sly1 displayed a temperaturesensitive growth phenotype as observed in the original sly1-ts strain. Sequencing of pXC3-sly1 revealed a G to A mutation near the PstI site that changes amino acid 266 from an arginine residue to a lysine residue.
Protein purification
Yeast GDI (Sec19p) was expressed in E.coli and purified as described previously (Garrett et al., 1994) . The peak fractions were dialyzed against Buffer 88 [20 mM HEPES (pH 7.0), 150 mM KOAc, 5 mM MgOAc] containing 1 mM DTT and 1 mM PMSF. Aliquots were frozen in liquid nitrogen and stored at -70°C. The COPII proteins (Barlowe et al., 1994) and Uso1p (Barlowe, 1997) were prepared as described. Purified LMA1 (Xu et al., 1997) was a generous gift of Zuoyu Xu (this department).
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Assays for docking and fusion of ER-derived vesicles Yeast semi-intact cells were prepared from log-phase cultures of strains grown at 23°C and stored frozen at -70°C (Baker et al., 1988) . Prior to assays, a tube of cells was quickly thawed and washed three times in Buffer 88 to remove cytosol, each wash was followed by centrifugation at 15 000 g (in 1.5 ml tubes, 12 000 r.p.m., Eppendorf model 5417 refrigerated centrifuge). Then, a 0.4 ml translocation reaction containing washed semi-intact cells, [ 35 S]pre-pro-α-factor and an ATP regenerating system was performed at 10°C for 10 min (Baker et al., 1988) . After translocation of [ 35 S]pre-pro-α-factor into ER membranes, semi-intact cells were chilled on ice and washed three times in Buffer 88 as described above.
For docking assays, semi-intact cells were incubated with COPII proteins and various additions in reactions that contained an ATPregenerating system and 0.1 mM GTP. The standard condition was 23°C for 30 min in 25 μl or as indicated in the figure legends. At the end of the incubations, tubes were placed on ice for 5 min and then centrifuged at 18 000 g (13 000 r.p.m. in Eppendorf model 5417 refrigerated centrifuge) for 3 min. The amount of freely diffusible ER-derived vesicles was quantified by measuring protease-protected Con A-Sepharoseprecipitable [ 35 S]gp-α-factor contained in the 18 000 g supernatant fraction as follows. A portion (10 μl) of the supernatant fraction was treated with trypsin (0.5 mg/ml) for 10 min on ice followed by trypsin inhibitor (1 mg/ml) for 10 min on ice. Membranes were then solubilized in 1% SDS at 95°C for 2 min, diluted 20-fold in IP buffer (25 mM Tris-HCl, 150 mM NaCl, 1% Triton X-100), and [ 35 S]gp-α-factor was precipitated with Con A-Sepharose at room temperature for 2 h (Baker et al., 1988) . A total reaction (no centrifugation after incubation) was processed in an identical manner. The percentage of freely diffusible vesicles represents the amount of [ 35 S]gp-α-factor contained in the 18 000 g supernatant fraction divided by the total amount of [ 35 S]gp-α-factor. Data points represent the average of duplicate determinations, where each duplicate set varied by less than 10%.
For transport assays, a parallel reaction with docking was performed and incubated at indicated temperatures. The standard reaction was 23°C for 60 min in 25 μl or as indicated in the figure legends. Transport reactions were stopped by addition of SDS to a final concentration of 1% and heated at 95°C for 2 min. Solubilized membranes were diluted 20-fold with IP buffer followed by the addition of anti-α1,6-mannosespecific serum and protein A Sepharose (Pharmacia Biotech). Outerchain modified forms of [ 35 S]gp-α-factor (reflecting delivery to the Golgi) were precipitated at room temperature for 2 h and processed as described previously (Baker et al., 1988) . The percentage transport is the amount of outer-chain modified [ 35 S]gp-α-factor divided by the total amount of protease-protected Con A-precipitable [ 35 S]gp-α-factor. For temperature-sensitive experiments, both docking and transport reactions were performed at 23, 26 and 29°C. Data points represent the average of duplicate determinations, where each duplicate set varied by less than 10%.
Membrane binding assay for Ypt1p and Uso1p
Strain CBY324, expressing a c-myc tagged version of Uso1p, was grown to mid-log phase, harvested and lysed in liquid nitrogen as described (Barlowe, 1997) . The lysate was centrifuged at 25 000 g (14 000 r.p.m. in a Sorvall SS34 rotor) for 15 min and aliquots of the supernatant fraction were frozen for storage at -70°C. For binding assays, 20 μl of extracts (~10 mg/ml protein) were incubated in the presence or absence of GDI with an ATP regenerating system and 0.2 mM GTP in 25 μl reactions at 20°C for 30 min. After chilling on ice, samples were diluted with 0.2 ml of Buffer 88 and yeast membranes were collected by centrifugation at 100 000 g (60 K in a TLA100 rotor, Beckman Instruments). The resulting membrane pellet was washed once with Buffer 88, and solubilized in 30 μl of SDS sample buffer. The amounts of Ypt1p, Sly1p, Uso1p and Emp47p bound to membranes were visualized by immunoblotting. To determine the effect of guanine nucleotide on membrane binding, GTPγS was exchanged onto GTPases through an incubation with 7 mM EDTA in the presence or absence of 0.4 mM GTPγS at 20°C for 5 min, followed by a second incubation at 20°C in the presence of additional MgOAc (final concentration 12 mM) (Garrett et al., 1993) . The effects of GDI on Ypt1p and Uso1p after GTPγS loading were determined as described above.
